Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - January 2002

  1. Nationwide campaign for vaccination of adults against rubella and measles-Costa Rica, 2001  MMWR Morb Mortal Wkly Rep 2001; 50(44): 976-9.
  2. Should clinicians get smallpox vaccinations?  ED Manag 2001; 13(11): suppl 3-4.
  3. Adhiyaman, V., Oke, A., Cefai, C., Adhiyaman, V., Oke, A., and Cefai, C.  
    Effects of yellow fever vaccination.  Lancet 2001; 358(9296): 1907-1908.
  4. Allsup, S. J., Gosney, M., Regan, M., Haycox, A., Fear, S., and Johnstone, F. C.
    Side effects of influenza vaccination in healthy older people: a randomised single-blind placebo-controlled trial.  Gerontology 2001; 47(6): 311-4.
  5. Andrianarivelo, M. R., Boisier, P., Rabarijaona, L., Ratsitorahina, M., Migliani, R., and Zeller, H.  
    . Mass vaccination campaigns to eradicate poliomyelitis in Madagascar: oral poliovirus vaccine increased immunity of children who missed routine programme. Trop Med Int Health 2001; 6(12): 1032-1039.
  6. Arya, S. C. 
    Effects of yellow fever vaccination.  Lancet 2001; 358(9296): 1908.
  7. Breukels, M. A., Zijde, E. M., van Tol, M. J., and Rijkers, G. T.
    Concentration and Avidity of Anti-Haemophilus influenzae Type b (Hib) Antibodies in Serum Samples Obtained from Patients for Whom Hib Vaccination Failed.  Clin Infect Dis 2002; 34(2): 191-197.
  8. Davis, R. L. and Bohlke, K.  
    Measles Vaccination and Inflammatory Bowel Disease: Controversy Laid to Rest?  Drug Saf 2001; 24(13): 939-946.
  9. Elkayam, O., Paran, D., Caspi, D., Litinsky, I., Yaron, M., Charboneau, D., and Rubins, J. B.  
    Immunogenicity and Safety of Pneumococcal Vaccination in Patients with Rheumatoid Arthritis or Systemic Lupus Erythematosus.  Clin Infect Dis 2002; 34(2): 147-153.
  10. Exner, M.  
    Successful vaccination for Lyme disease: a novel mechanism?  Expert Opin Biol Ther 2001; 1(5): 783-93.
  11. Gasior-Chrzan, B.  
    Delayed granulomatous lesion at the bacillus Calmette-Guerin vaccination site.  Acta Derm Venereol. 2001 Aug-Sep;81(4):302-4.
  12. Glass, T. A. and Schoch-Spana, M.  
    Bioterrorism and the People: How to Vaccinate a City against Panic.  Clin Infect Dis 2002; 34(2): 217-223.
  13. Hutchins, S. S., Dezayas, A., Blond, K. L., Heath, J., Bellini, W., Audet, S., Beeler, J., Wattigney, W., and Markowitz, L.
    Evaluation of an Early Two-Dose Measles Vaccination Schedule.  Am J Epidemiol 2001; 154(11): 1064-1071.
  14. Kakurai, M., Kiyosawa, T., Ohtsuki, M., and Nakagawa, H.  
    Multiple lesions of granuloma annulare following BCG vaccination: case report and review of the literature.  Int J Dermatol 2001; 40(9): 579-581.
  15. Khetsuriani, N., Bisgard, K., Prevots, D. R., Brennan, M., Wharton, M., Pandya, S., Poppe, A., Flora, K., Dameron, G., and Quinlisk, P.  
    Pertussis outbreak in an elementary school with high vaccination coverage.  Pediatr Infect Dis J 2001; 20(12): 1108-1112.
  16. Leggat, P. A.  
    Book Review: The Traveller's Pocket Medical Guide and International Certificate of Vaccination,3rd edition.  J Travel Med 2001; 8(6): 336.
  17. Martin, M., Weld, L. H., Tsai, T. F., Mootrey, G. T., Chen, R. T., Niu, M., and Cetron, M. S.
    Advanced Age a Risk Factor for Illness Temporally Associated with Yellow Fever Vaccination.  Emerg Infect Dis 2001; 7(6): 945-951.
  18. Mortimer, E. A. Jr, Ball, R., Ball, L. K., Wise, R. P., Braun, M. M., Beeler, J. A., and Salive, M. E.  
    Stevens-Johnson Syndrome After Vaccination.  Pediatr Infect Dis J 2001; 20(8): 818-819.
  19. Poehling, K. A., Speroff, T., Dittus, R. S., Griffin, M. R., Hickson, G. B., and Edwards, K. M.
    Predictors of influenza virus vaccination status in hospitalized children.  Pediatrics 2001; 108(6): 99.
  20. Pollard, A. J. and Scheifele, D.  
    Meningococcal disease and vaccination in North America.  J Paediatr Child Health 2001; 37(5): 20-27.
  21. Schaberg, T.
    [Protective Vaccination Against Pneumococci].  Pneumologie 2001; 55(12): 543-545.
  22. Schwartz, B. and Orenstein, W. A.  
    Vaccination Policies and Programs: The Federal Government's Role in Making the System Work.  Prim Care 2001; 28(4): 697-711.
  23. Scrimgeour, E. M. and Mehta, F. R.  
    Rabies in Oman: failed postexposure vaccination in a lactating woman bitten by a fox. Int J Infect Dis 2001; 5(3): 160-2.
  24. Skull, S. and Butler, J.  
    Meningococcal vaccination for adolescents? An economic evaluation in Victoria.  J Paediatr Child Health 2001; 37(5): 28-33.
  25. Taranger, J., Trollfors, B., Bergfors, E., Knutsson, N., Lagergard, T., Schneerson, R., and Robbins, J. B.  
    Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine.  Pediatrics 2001; 108(6): 115.
  26. Troillet, N. and Laurencet, F.  
    Effects of yellow fever vaccination.  Lancet 2001; 358(9296): 1908-1909.
  27. Verstraeten, T., Baughman, A. L., Cadwell, B., Zanardi, L., Haber, P., Chen, R. T., and the Vaccine Adverse Event Reporting System Team  
    Enhancing Vaccine Safety Surveillance: A Capture-Recapture Analysis of Intussusception after Rotavirus Vaccination.  Am J Epidemiol 2001; 154(11): 1006-1012.
  28. Werfel, U. and Popp, W.  
    Effects of yellow fever vaccination.  Lancet 2001; 358(9296): 1909.
  29. Zimmerman, R. K. and Ball, J. A.  
    Adult Vaccinations.  Prim Care 2001; 28(4): 763-790.

Back to Top